AllianceBernstein
SANA icon

AllianceBernstein’s Sana Biotechnology SANA Stock Holding History

AllianceBernstein’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Hold
186,945
– – ﹤0.01% 2664
2026
Q1 		$761K Hold
186,945
– – ﹤0.01% 2447
2025
Q4 		$761K Sell
186,945
-9,800
-5% -$43.9K ﹤0.01% 2455
2025
Q3 		$698K Hold
196,745
– – ﹤0.01% 2511
2025
Q2 		$537K Buy
196,745
+32,550
+20% +$67.2K ﹤0.01% 2605
2025
Q1 		$276K Buy
164,195
+15,810
+11% +$44.2K ﹤0.01% 2816
2024
Q4 		$242K Sell
148,385
-21,690
-13% -$64.7K ﹤0.01% 2974
2024
Q3 		$708K Hold
170,075
– – ﹤0.01% 2487
2024
Q2 		$929K Buy
170,075
+44,750
+36% +$357K ﹤0.01% 2345
2024
Q1 		$1.25M Sell
125,325
-1,270
-1% -$9.51K ﹤0.01% 2142
2023
Q4 		$517K Hold
126,595
– – ﹤0.01% 2598
2023
Q3 		$490K Hold
126,595
– – ﹤0.01% 2582
2023
Q2 		$755K Buy
126,595
+10,200
+9% +$58.8K ﹤0.01% 2430
2023
Q1 		$381K Buy
116,395
+8,800
+8% +$35.2K ﹤0.01% 2679
2022
Q4 		$425K Hold
107,595
– – ﹤0.01% 2716
2022
Q3 		$646K Hold
107,595
– – ﹤0.01% 2517
2022
Q2 		$692K Buy
107,595
+3,099
+3% +$19.7K ﹤0.01% 2528
2022
Q1 		$863K Buy
104,496
+200
+0.2% +$1.62K ﹤0.01% 2478
2021
Q4 		$1.61M Buy
104,296
+1,300
+1% +$25.1K ﹤0.01% 2260
2021
Q3 		$2.32M Buy
102,996
+73,500
+249% +$1.54M ﹤0.01% 2081
2021
Q2 		$580K Buy
29,496
+15,767
+115% +$357K ﹤0.01% 2756
2021
Q1 		$460K Buy
+13,729
New +$447K ﹤0.01% 2691

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

AllianceBernstein's SANA Position: Q2 2026 in Review

AllianceBernstein held its Sana Biotechnology (SANA) position steady in Q2 2026 at 186,945 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

AllianceBernstein first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.32M in Q3 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • AllianceBernstein held 186,945 shares of Sana Biotechnology worth $538K as of Q2 2026.
  • AllianceBernstein left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2664 holding.
  • AllianceBernstein first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • AllianceBernstein's Sana Biotechnology position peaked at $2.32M in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.